JUN 13, 2018 05:42 AM PDT

Psychedelics May Serve as Potential Treatment for Depression

WRITTEN BY: Nouran Amin

Research at the University of California is examining the effect of hallucinogenic drugs on the brain and how this research can potentially provide some answers in treating depression and other mental disorders. The latest findings have shown the ability of these psychedelic drugs to change the neurons and glial cells present in the brains of rat and flies; primarily increasing the connectivity between neuronal cells.

Although depression has long been believed to be asocated with chemical imbalances in the brain, recent research has provided evidence of how structural changes in parts of the brain can also be associated with depression. For example, in a recent fMRI study, the hippocampus was found to be around 9 to 13 percent smaller among individuals afflicted with depression.

Senior author David E. Olson discussed that “one of the hallmarks” of depression is the presence of shriveled up neurites in the prefrontal cortex of the brain. The prefrontal cortex is the region of the brain concerned with emotion and mood regulation. “People have long assumed that psychedelics are capable of altering neuronal structure, but this is the first study that clearly and unambiguously supports that hypothesis,” he said. “What is really exciting is that psychedelics seem to mirror the effects produced by ketamine.”

Despite multiple limitations, Ketamine was studied to have antidepressant properties. Olson and co-researchers were particularly interested in how psychedelics could hold the similar effects of ketamine on neurons grown in a petri dish. But after treatment with a dose of DMT (a psychedelic compound), rats had an increase in the number of dendritic spines, which was similar when these rat model were treated with ketamine.

"These are some of the most powerful compounds known to affect brain function, it's very obvious to me that we should understand how they work," said Olson. With these research findings, it was crucial to bring the risks of psychedelics into light. For one, the drugs could induce forms of psychotic disorders particularly in individuals who are genetically predisposed.

The researchers tested psychedelics from the amphetamine, tryptamine, and ergoline drug classes. Talaverabeads/Pixabay, Image via MedicalDaily.com

A professor of clinical psychiatry, by the name of Richard A. Friedman, at the Weill Cornell Medical College, believes that psychedelics may be behaviorally toxic, as well as an addictive similar to cocaine or alcohol. “Psychedelics might turn out to have real promise, but that needs to be proven through large, rigorous, placebo-controlled trials. We’re not there yet,” he cautioned.

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 22, 2019
Drug Discovery & Development
OCT 22, 2019
Lab-on-a-chip Advances Search for Anti-Clotting Drugs
A novel ‘lab-on-a-chip’ the size of a postage stamp could soon advance the developments of safer anti-clotting drugs for heart attack and strok...
OCT 22, 2019
Clinical & Molecular DX
OCT 22, 2019
Muscular Dystrophy Drug by Sarepta Therapeutics: Approval or Rejection by Drug Regulating Authorities?
Duchenne Muscular Dystrophy (DMD is a rare, genetic disorder that hampers muscle movement and is the most common pediatric muscular dystrophy. I...
OCT 22, 2019
Cancer
OCT 22, 2019
Cancer drugs don't work the way we thought
New research recently published in the journal Science Translational Medicine surprises the oncological community with findings that a protein previously t...
OCT 22, 2019
Drug Discovery & Development
OCT 22, 2019
Leukemia Drug Effective for Treating Childhood Brain Cancer
Scientists at the University of California-San Diego have found that a chronic myeloid leukemia drug was found to treat medulloblastoma in mouse models mor...
OCT 22, 2019
Drug Discovery & Development
OCT 22, 2019
Injectable Implant Drug Shows Promise for HIV Treatment
In a study published in Nature Communications, alternative treatment was shown to have promising results for HIV as opposed to a daily pill regimen. Scient...
OCT 22, 2019
Cardiology
OCT 22, 2019
Heart Attacks Without The Risk
Following a heart attack, as the heart heals, scar tissue forms. This issue is less flexible than healthy heart tissue and may encumber the heart's abi...
Loading Comments...